GlassScriptPhysician profile
Kenneth F Menchion
NPI 1508822776
$1,129.95
in general payments reported to CMS, 2019-2025
17 companies · $61.00 in 2025
The $61.00 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $31.11 · 2021: $275 · 2022: $194 · 2023: $275 · 2024: $151 · 2025: $61.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461 · Education: $25.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.78 |
| Education | $25.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $232.87 | 2019-2024 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Cardiva Medical, INC. | $169.45 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boston Scientific Corporation | $139.72 | 2020-2024 | Varithena Administration Pack |
| E.R. Squibb & Sons, L.L.C. | $83.47 | 2019-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $79.01 | 2019-2021 | |
| Amarin Pharma, INC. | $66.98 | 2021-2022 | |
| Pfizer INC. | $62.85 | 2019-2025 | |
| Abbott Laboratories | $50.40 | 2021-2022 | |
| Abiomed | $43.52 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $39.29 | 2023 | Verquvo |
| Amgen INC. | $31.06 | 2019 | |
| Medtronic, INC. | $31.00 | 2023 | Endurant Iis |
| Inari Medical, INC. | $28.59 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Actelion Pharmaceuticals US, INC. | $22.60 | 2023 | Opsumit |
| Cvrx, INC. | $21.53 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $18.23 | 2022 | |
| Lemaitre Vascular, INC. | $9.38 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Menchion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.